tiprankstipranks
Pharma Mar SA (PHMMF)
OTHER OTC:PHMMF
US Market
Want to see PHMMF full AI Analyst Report?

Pharma Mar SA (PHMMF) Income Statement

57 Followers

Pharma Mar SA Income Statement

Last quarter (Q4 2025), Pharma Mar SA's total revenue was €90.48M, an increase of 87.08% from the same quarter last year. In Q4, Pharma Mar SA's net income was €59.66M. See Pharma Mar SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 221.39M€ 174.85M€ 158.15M€ 196.34M€ 229.83M
Gross Profit
€ 209.13M€ 166.67M€ 148.54M€ 182.70M€ 213.39M
Operating Expenses
€ 168.85M€ 160.20M€ 152.37M€ 138.27M€ 121.04M
Depreciation and Amortization
€ 8.02M€ 6.77M€ 5.76M€ 5.90M€ 5.58M
EBITDA
€ 48.30M€ 21.23M€ 4.55M€ 52.07M€ 104.08M
Operating Income
€ 40.28M€ 6.47M€ -3.83M€ 44.07M€ 92.45M
Other Income/Expenses
€ 19.38M€ 5.52M€ 204.00K€ -281.00K€ -6.36M
Pretax Income
€ 59.65M€ 11.98M€ -3.62M€ 43.79M€ 95.13M
Net Income
€ 74.99M€ 26.13M€ 1.14M€ 49.36M€ 92.86M
Per Share Metrics
Basic EPS
€ 4.36€ 1.48€ 0.06€ 2.73€ 5.14
Diluted EPS
€ 4.36€ 1.48€ 0.06€ 2.73€ 5.13
Weighted Average Shares Outstanding
17.21M 17.54M 17.90M 18.05M 18.07M
Weighted Average Shares Outstanding (Diluted)
17.21M 17.56M 17.92M 18.06M 18.09M
Currency in EUR

Pharma Mar SA Earnings and Revenue History